Strength Seen in Alkermes (ALKS): Stock Up 8.5% - Analyst Blog

By Zacks Equity Research,

Shutterstock photo

Alkermes plc ( ALKS ) was a big mover last session, as the company saw its shares surge by about 8.5% on the day. The move came on solid volume too, with far more shares changing hands than in a normal session. This reverses the recent trend of the company, as the stock is now trading above the volatile price range of $30.17 to $35.21 in the past one-month time frame.

The company has seen no estimate revision in the past 2 months. Moreover, its earnings consensus has remained stagnant over the same time frame. However, this recent price action is certainly encouraging, so make sure to keep a close watch of this firm in the near future.

ALKS currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better performing med-biomed/gene stocks include Actelion Ltd. ( ALIOF ), AMAG Pharmaceuticals, Inc. ( AMAG ) and Gentium S.p.A ( GENT ). All these stocks carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>


ALKERMES INC (ALKS): Free Stock Analysis Report

AMAG PHARMA INC (AMAG): Free Stock Analysis Report

GENTIUM SPA-ADR (GENT): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Business , Stocks
Referenced Stocks: ALIOF , ALKS , AMAG , GENT

More from


Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by